TME Pharma Publishes Its Semi Annual Results and Half-Year Report Berlin, Germany, 18:00 CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotech-company with clinical assets for brain cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results